Skip to content

Cap Assisted Upper Endoscopy to Visualize the Major Duodenal Papilla

The Use of Cap Assisted Forward Viewing Esophagogastroduodenoscopy to Examine the Major Duodenal Papilla

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02877797
Acronym
Kappa-I
Enrollment
101
Registered
2016-08-24
Start date
2016-02-29
Completion date
2016-08-31
Last updated
2016-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visualisation and Evaluation of Ampulla of Vater

Brief summary

Aim of the present study is the evaluation of the diagnostic value of a cap assisted upper GI-endoscopy compared to a standard upper GI-endoscopy regarding the visualisation and evaluation of the papilla duodeni major.

Interventions

DEVICECap

cap assisted esophagogastroduodenoscopy

Sponsors

Technical University of Munich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Indication of Esophagogastroduodenoscopy independent from the study * Written informed * Age ≥ 18 years

Exclusion criteria

* Absence of written informed consent * Contraindication or absence of informed consent regarding sedation with Propofol * Postoperativ changes of the upper GI-tract * Intention of endoscopic intervention * Suspicion of upper GI-bleeding * Suspicion of stenosis of the esophagus * Stent in the papilla duodeni major * ASA (American Society of Anesthesiologists) classification ≥ 3

Design outcomes

Primary

MeasureTime frameDescription
Rate of complete visualisation of papilla duodeni major120 secondsvisualisation: none, incomplete, complete

Secondary

MeasureTime frameDescription
Diagnostic yield in the upper GI-tractup to 10 minutesAll pathological findings which are seen during the examination should be reported (e.g. reflux esophagitis, Barret's esophagus, duodenal erosions, etc)
time of investigationup to 10 minutesDuration of Esophagogastroduodenoscopy
complication rateup to one weekAny complications related to the examination within one week would be reported.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026